GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » Cash per Share

Dr Hoenle AG (XTER:HNL) Cash per Share : €1.41 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Dr Hoenle AG's Cash per Share for the quarter that ended in Dec. 2023 was €1.41.


Dr Hoenle AG Cash per Share Historical Data

The historical data trend for Dr Hoenle AG's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Cash per Share Chart

Dr Hoenle AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.65 5.64 1.99 1.18 1.54

Dr Hoenle AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.11 1.15 1.54 1.41

Dr Hoenle AG Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Dr Hoenle AG's Cash per Share for the fiscal year that ended in Sep. 2023 is calculated as:

Dr Hoenle AG's Cash per Share for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Hoenle AG  (XTER:HNL) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Dr Hoenle AG Cash per Share Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Hoenle AG (XTER:HNL) Business Description

Traded in Other Exchanges
Address
Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines